Clinical Trials › NCT05170126
Recruiting
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Sponsored by Bristol-Myers Squibb
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 1182
Target enrollment
1
U.S. states
Jul 2022
Start date
Jun 2032
Expected completion
Conditions studied
Multiple Sclerosis
Where this trial is running (2 sites)
Maryland2 sites
Bethesda · Bethesda
MS centers in Maryland
Compare treatment centers near a trial site by center type, providers and trials.
View Maryland centersThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.